Jongen-Lavrencic et al., [131] reported that miR-155 is upregulated in hematopoietic stem cells carrying FLT3-ITD and nucleophosmin (NPM1) gene mutations of AML patients. This evidence concerns the gene NPM1 and acute myeloid leukemia.